Halma plc has acquired PeriGen, Inc., a perinatal safety company that applies artificial intelligence to improve safety in childbirth. Based in the UK, Halma is a FTSE 100 global group of life-saving technology companies. The company identifies and invests in companies in three areas: healthcare, industrial safety technology, and environmental monitoring.
PeriGen’s technology helps protect mothers and their unborn babies by using AI tools to continuously monitor laboring patients to identify and highlight troubling trends over the course of labor. PeriGen’s software runs at hundreds of facilities in North America, including academic medical centers, community hospitals and rural care centers. It integrates with all major electronic medical records and can augment a hospital’s existing fetal monitoring equipment.
“The last few years have been transformational for PeriGen and demonstrates the potent combination of aligning the interests of a management team, investors and, most importantly, customers and their patients,” said Matthew Sappern, PeriGen CEO. “Years of financial stability and product discipline have led us to a point where we can make impact at scale in North America and soon beyond as part of Halma plc. We are excited for what the future holds for our company.”
PeriGen was advised in this transaction by investment bank Canaccord Genuity.